CAREER: Optimal Management of Chronic Diseases Caused by Infections

职业:感染引起的慢性病的最佳管理

基本信息

  • 批准号:
    1452999
  • 负责人:
  • 金额:
    $ 50万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
    Standard Grant
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-09-01 至 2021-08-31
  • 项目状态:
    已结题

项目摘要

The research objective of this Faculty Early Career Development (CAREER) Program award is to study the design of optimal population-based disease surveillance policies and treatment prioritization strategies for chronic infectious diseases in resource-limited settings. The project particularly focuses on the optimal control of hepatitis C Virus (HCV), an epidemic affecting nearly 2 percent of the entire US population, but also applies to many other chronic diseases. Untreated HCV infection is the leading cause of cirrhosis and hepatocellular carcinoma, the fastest-growing cause of cancer-related deaths in the US. If successful, results from this research may improve hepatocellular carcinoma surveillance and HCV treatment prioritization decisions in practice and can inform prevention and treatment decisions at the national level in terms of guideline development. Under this project, in collaboration with several medical researchers, a PhD student will be rigorously trained to apply systems modeling methodologies to the healthcare area. In addition, several high school and undergraduate students will be engaged into these research activities. The results of the project will be widely disseminated to both engineering and medical communities through paper publications and conference presentations.Many health policy questions, such as optimal disease surveillance and treatment prioritization decisions for chronic infectious diseases, cannot be answered through the traditional research methods in medicine, such as randomized control trials and observational studies. This study will use data-driven mathematical models to underpin some of such complex health policy decisions. The resulting stochastic optimization models are non-standard, large scale, and computationally challenging. Therefore, this study will either create new approaches or extending the existing methodology to account for the critical features of the disease epidemiology, resource limitations, and management strategies. An important component of the research is careful parameterization and calibration of the models using some of the largest datasets in the nation. While this project mainly focuses on hepatocellular carcinoma and HCV, the themes of this study can be generalized and applied to several other disease management problems.
该学院早期职业发展(CAREER)计划奖的研究目标是研究在资源有限的环境中针对慢性传染病设计最佳的基于人群的疾病监测政策和治疗优先策略。该项目特别关注丙型肝炎病毒 (HCV) 的最佳控制,这种流行病影响了美国近 2% 的人口,但也适用于许多其他慢性疾病。未经治疗的丙型肝炎病毒感染是肝硬化和肝细胞癌的主要原因,而肝硬化和肝细胞癌是美国癌症相关死亡增长最快的原因。 如果成功,这项研究的结果可能会改善实践中的肝细胞癌监测和丙型肝炎治疗优先决策,并可以为国家层面的指南制定提供预防和治疗决策信息。在该项目下,与几位医学研究人员合作,一名博士生将接受严格的培训,将系统建模方法应用于医疗保健领域。此外,一些高中生和本科生将参与这些研究活动。该项目的成果将通过论文出版物和会议报告向工程界和医学界广泛传播。许多卫生政策问题,例如慢性传染病的最佳疾病监测和治疗优先决策,无法通过传统的医学研究方法(例如随机对照试验和观察性研究)来回答。这项研究将使用数据驱动的数学模型来支持一些此类复杂的卫生政策决策。由此产生的随机优化模型是非标准的、大规模的且计算上具有挑战性。因此,本研究将创建新方法或扩展现有方法,以考虑疾病流行病学、资源限制和管理策略的关键特征。该研究的一个重要组成部分是使用全国一些最大的数据集对模型进行仔细的参数化和校准。虽然该项目主要关注肝细胞癌和丙型肝炎病毒,但本研究的主题可以推广并应用于其他几个疾病管理问题。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Turgay Ayer其他文献

MSR155 Assessing the Effectiveness of Large Language Models in Automating Systematic Literature Reviews: Findings from Recent Studies
《MSR155:评估大型语言模型在自动化系统文献综述中的有效性:近期研究结果》
  • DOI:
    10.1016/j.jval.2025.04.1306
  • 发表时间:
    2025-07-01
  • 期刊:
  • 影响因子:
    6.000
  • 作者:
    Sumeyye Samur;Bhakti Mody;Rachael Fleurence;Elif Bayraktar;Turgay Ayer;Jag Chhatwal
  • 通讯作者:
    Jag Chhatwal
Prevalence and Economic Burden of Chronic Lymphocytic Leukemia (CLL) in the Era of Oral Targeted Therapies
  • DOI:
    10.1016/j.clml.2015.07.653
  • 发表时间:
    2015-09-01
  • 期刊:
  • 影响因子:
  • 作者:
    Nitin Jain;Qiushi Chen;Turgay Ayer;William G. Wierda;Susan O'Brien;Michael Keating;Hagop M. Kantarjian;Jagpreet Chhatwal
  • 通讯作者:
    Jagpreet Chhatwal
P60 Feasibility of Replicating a Published Health Economic Model From an ICER Report Using Generative AI
P60 使用生成式人工智能从 ICER 报告中复制已发表健康经济模型的可行性
  • DOI:
    10.1016/j.jval.2025.04.079
  • 发表时间:
    2025-07-01
  • 期刊:
  • 影响因子:
    6.000
  • 作者:
    Jag Chhatwal;Sumeyye Samur;Jade Xiao;Elif Bayraktar;Ismail F. Yildirim;Turgay Ayer
  • 通讯作者:
    Turgay Ayer
A LIFE COURSE APPROACH TO BLOOD PRESSURE AND CARDIOVASCULAR RISK
  • DOI:
    10.1016/s0735-1097(15)61407-3
  • 发表时间:
    2015-03-17
  • 期刊:
  • 影响因子:
  • 作者:
    Emir Veledar;Anthony Bonifonte;Turgay Ayer;Peter Wilson
  • 通讯作者:
    Peter Wilson
MSR30 Evaluating Generative AI in Replicating Health Economic Models: A Case Study on Ulcerative Colitis
  • DOI:
    10.1016/j.jval.2025.04.1182
  • 发表时间:
    2025-07-01
  • 期刊:
  • 影响因子:
    6.000
  • 作者:
    Sumeyye Samur;Jakob Langer;Emir Gursel;Ismail F. Yildirim;Turgay Ayer;Jag Chhatwal;Ipek Ozer Stillman
  • 通讯作者:
    Ipek Ozer Stillman

Turgay Ayer的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Turgay Ayer', 18)}}的其他基金

RAPID: Collaborative Research: Mitigation and Suppression of Coronavirus Pandemic with Data-driven RAPID Decisions Using COVID-19 Simulator
RAPID:协作研究:使用 COVID-19 模拟器通过数据驱动的 RAPID 决策缓解和抑制冠状病毒大流行
  • 批准号:
    2035360
  • 财政年份:
    2020
  • 资助金额:
    $ 50万
  • 项目类别:
    Standard Grant
SCH: INT: Collaborative Research: Smart Intervention Strategies for Hepatitis C Elimination
SCH:INT:合作研究:消除丙型肝炎的智能干预策略
  • 批准号:
    1722614
  • 财政年份:
    2017
  • 资助金额:
    $ 50万
  • 项目类别:
    Standard Grant
SCH: EXP: Smart Adaptive Adherence-Enhancing Intervention Strategies for Breast Cancer Prevention
SCH:EXP:预防乳腺癌的智能适应性依从性增强干预策略
  • 批准号:
    1601084
  • 财政年份:
    2017
  • 资助金额:
    $ 50万
  • 项目类别:
    Standard Grant
GOALI: Improving Blood Collection, Production, and Inventory Operations
目标:改善血液采集、生产和库存运营
  • 批准号:
    1335137
  • 财政年份:
    2014
  • 资助金额:
    $ 50万
  • 项目类别:
    Standard Grant

相似海外基金

Collaborative Research: CISE-MSI: DP: IIS RI: Research Capacity Expansion via Development of AI Based Algorithms for Optimal Management of Electric Vehicle Transactions with Grid
合作研究:CISE-MSI:DP:IIS RI:通过开发基于人工智能的算法来扩展研究能力,以实现电动汽车与电网交易的优化管理
  • 批准号:
    2318611
  • 财政年份:
    2023
  • 资助金额:
    $ 50万
  • 项目类别:
    Standard Grant
A concept mapping approach to DevelOP a ToolkIt to iMprove medicAtion self-management for persons with spinaL cord injury (OPTIMAL-SCI)
开发工具包以改善脊髓损伤患者的药物自我管理的概念图方法 (OPTIMAL-SCI)
  • 批准号:
    495188
  • 财政年份:
    2023
  • 资助金额:
    $ 50万
  • 项目类别:
VIPCare: Virtual Predictive Care workflow with integrated surveillance for optimal care protocol selection and management in at-risk prostate cancer patients
VIPCare:虚拟预测护理工作流程,具有综合监测功能,可为高危前列腺癌患者提供最佳护理方案选择和管理
  • 批准号:
    10758350
  • 财政年份:
    2023
  • 资助金额:
    $ 50万
  • 项目类别:
Collaborative Research: CISE-MSI: DP: IIS RI: Research Capacity Expansion via Development of AI Based Algorithms for Optimal Management of Electric Vehicle Transactions with Grid
合作研究:CISE-MSI:DP:IIS RI:通过开发基于人工智能的算法来扩展研究能力,以实现电动汽车与电网交易的优化管理
  • 批准号:
    2318612
  • 财政年份:
    2023
  • 资助金额:
    $ 50万
  • 项目类别:
    Standard Grant
Degradation Analysis, Optimal Design, and Intelligent Management of Lithium Ion Batteries
锂离子电池的劣化分析、优化设计与智能管理
  • 批准号:
    RGPIN-2018-05471
  • 财政年份:
    2022
  • 资助金额:
    $ 50万
  • 项目类别:
    Discovery Grants Program - Individual
Stochastic optimal control problems in risk management
风险管理中的随机最优控制问题
  • 批准号:
    RGPIN-2020-04338
  • 财政年份:
    2022
  • 资助金额:
    $ 50万
  • 项目类别:
    Discovery Grants Program - Individual
Pursuit of optimal management for non-culprit lesions in acute coronary syndrome patients..
追求急性冠状动脉综合征患者非罪魁祸首的最佳治疗。
  • 批准号:
    22K08191
  • 财政年份:
    2022
  • 资助金额:
    $ 50万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Design and Management of Responsible and Optimal Global Supply Chains for Retailing
负责任且最优的全球零售供应链的设计和管理
  • 批准号:
    RGPIN-2020-04790
  • 财政年份:
    2022
  • 资助金额:
    $ 50万
  • 项目类别:
    Discovery Grants Program - Individual
Optimal management strategy for short food supply chains considering heterogeneity and uncertainty
考虑异质性和不确定性的短食品供应链优化管理策略
  • 批准号:
    22K04607
  • 财政年份:
    2022
  • 资助金额:
    $ 50万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Sustainable Stormwater Management Approach: Optimal Implementation of Low Impact Development Systems
可持续雨水管理方法:低影响开发系统的优化实施
  • 批准号:
    RGPIN-2022-05461
  • 财政年份:
    2022
  • 资助金额:
    $ 50万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了